Health and Family Welfare Government Departments Closing in 27 days TDR #57744626

Tender For Tender for Tablet ,Injection and Miscellaneous Items D (Non EDL items) 2026-27

Issued by Government Departments · Surat, Gujarat
Tender Value
Ref. Documents
Estimated cost
Bid Submission
27 Oct 2026
27 days left
EMD
Ref. Documents
Bank guarantee accepted
Document Fee
5000
Non-refundable
Tender Type
Online

Tender Overview

Competition Type
NCB
Bidding Type
Tender
Location / State
Surat → Gujarat
EMD Exemption
Not Available
Quantity
Not Available

Project Description

Tender for Tablet ,Injection and Miscellaneous Items D (Non EDL items) 2026-27- cyclosporine emulsion 0.05percentage + glycerine, castor oil, polysorbate 80, carbomar 1342 (per unim 0.4ml each), dorzolamide (2percentage) & timolol (0.5percentage) eye drops, flubiprofen 0.3percentage drops., flurbiprofen sodium 0.03percentage w/v + hydroxy prophyl methyl cellulose ( hpmc) -0.25percentage + polymercuric nitrate -0.002percentage w/v, gentamycin sulphate 0.3percentage with dexamethasone drops, nepafenac micronized suspension 0.1percentage with stabilzed oxychloro complex ( purite) (bak free), nephazolin hcl 0.1percentage methyl cellulose 0.1percentage chloepheniramine meleate 0.01percentage phenyl mercuric nitrate 0.001percentage eye drops., ofloxacin 0.3percentage with dexamethasone 0.1percentage eye/ear drops., ofloxacin eye/ear drops. 0.3percentage, sterile opthalmic irrigating solution, sterile opthalmic irrigating solution balanced salt solution contains: nacl 0.49percentage, kcl-0.075percentage cacl-0.3percentage, sod.acetate 0.39percentage sod.citrate 0.17percentage q.s.h2o.for inj. (glass bottle) autoclavable, tobramycin 0.3percentage eye drosp., paediatric department items: ambroxol hydrochloride syrup, amoxycillin and clavulinic acid syrup, b-complex syrup., caffine citrate (1ml-20mg) 1.5ml vial syrup, caffine citrate (1ml-20mg) 1ml vial syrup, caffine citrate (1ml-20mg) 3ml vial syrup, calcium,phosphorus,magnasium,zinc & vitamin d3 syrup, cefpodoxime syrup, codeine syrup, cough syrup containing:yashtimadhu (glycyrrhiza glabra), tulasi ( ocimum sactum), madhu ( mel despumatum), kantakari (solanum xanthocarpum), vasakaadhatoda vasica) vidanga( embelia ribes), draksha ( vitis vinifera), jatipatri (myristica fragrans), guggulu (balsamodendron mukul), dextrometharphan hydrobromide + cpm + phenylephrine syp., digoxin syrup, each 100 gram of cream contains: aqueous extract of triticum vulgare 15 gm + phenoxyethanol 1gm, erythromycin ( 125mg / 5ml ) syrup, feracrylum 1percentage v/v solution- 100ml bottle, frusemide syrup, iron drops, levocarnitine (1ml equal to 100mg) syrup, levosalbutamol syrup, linezolid syrup, lugols iodine solution (3.5percentage), metoclopramide hydrochloride (5mg/5ml) syrup, phenytion syrup, pottassium chloride syrup, promethazine syrup 5mg/5ml., rifaximin suspension100 mg/5ml, vitamin d3 (800iu/ml), vitamin -e (400iu/ml) syrup, zidovudine syrup, respiratory medicine department items: levosalbutamol respules + ipratropium bromid respules, nebulization respules ( glycopyronium), nebulization respules (ipratropium + levosalbutamol), formeterol 20 microgram+budesonide 0.5 gm respules, formeterol 20 microgram+budesonide 1 gm respules, buprinorphin 10mcg patch, buprinorphin 20mcg patch, buprinorphin 5mcg patch, dextrose powder ip, protein powder 200 gms with vit a,b1,b2,b6, paediatric department items: human milk fortifier (1gm sachet), mther milk fortifier (0.5gm sachet), mther milk fortifier (1gm sachet), probiotic sachet for neonatal use, simyl mct oil 100ml, radiology department items: ultrasound contrast sulpher hexafluride, iodixanol 320mg non ionic, dimeric iso osmolar u.s. fda approved ct contrast injection, iodixanol 320mg/ml injection, iohexol 300mg non ionic, low osmolar with low viscosity u.s. fda approved ct contrast injection, iopamidol solution 300mg/ml injection, iopamidol solution 350mg/ml injection, oral contrast for c.t. scan 10gm.sodium diatrizoate 66gm. meglumine diatrizoate, oral contrast for c.t. scan barium sulphate solution for c.t. scan i.p. 7gm/100ml., oral negative contrast mannitol, sodalime - highco2 absorption capacity, it should be in pallete form having high and uniform packing density.it should be high abrasion resistant due to less dust formation. there should be no compound a and carbon monoxide formation, terpentine oil., succinylated balance gelatin for 4percentage succinylated gelatin molecule with a molecular weight of 30,000 daltons sodium- 151mmol/l potassium- 4 mmol/l, calcium- 1 mmol/l magnesium- 1 mmol/l, acetate- 24.0, chloride- 103mmol/l, ph- 7.4, osmolality- 284 mosm/kg in a 500ml specially patented plastic ecoflac plus bottle, succinylated gelatin for 4percentage succinylated gelatin molecule with a molecular weight of 30,000 daltons containing na+ : 154 mmol/l and cl- : 120 mmol/l, with a colloid osmotic pressure of 33.3 mm of hg; in a 500ml specially patented plastic ecoflac plus bottle, tablet lactoferrin 100mg +disodium guanosine 5 -monophosphate 10mg, tablet lactoferrin 100mg +disodium guanosine 5 -monophosphate 10mg + magnesium 200mg, carboxy methyl cellulose (1.0percentage)+ stabilized oxychloro complex ( purite) - 0.0075percentage with boric acid, cacl, mgcl , sodium borate, nacl, carboxy methyl cellulose (0.5percentage)+ stabilized oxychloro complex ( purite) - 0.005percentage, injection dexamethasone 0.7mg intravitreal implant, injection botulinum toxin type a 200 unit, fast acting insulin aspart 100iu/ml in 3ml pfs type of insulin:ultra short acting prandial, injection concizumab 15mg pen device, injection concizumab 300mg pen device, human papillomavirus 9-valent vaccine 0.5ml, human albumin solution i.p. 5percentage 250ml, human albumin solution i.p. 25percentage 100ml, injection agalsidase alfa (r-dna origin)1mg/ml, injection idursulfase (r-dna origin)2mg/ml, injection velaglucerase alfa (r-dna origin) 4.0ml, injection vedolizumab 300mg, human c1 esterase inhibitor 500iu e.p., injection semagluide 0.25mg, injection semagluide 0.5mg, injection semagluide 1.0mg, injection semagluide 1.7mg, injection semagluide 2.4mg, injection pegylated factorviii (250iu/vial), injection pegylated factorviii (500iu/vial), nonacog beta pegol, glycopegylated recombinant factor-ix 250iu, nonacog beta pegol, glycopegylated recombinant factor-ix 1000iu, hemostsit gelatin thrombin matrix 2500iu, thrombin + fibrin seant 2ml, lactoferrin 100mg+ ferroue bisglycinate 200mg+ folic acid 400mcg, 3 in one tpn 1000ml for central/periperal iv emlusions with 80percentage olive 20percentage soya lipid, amino acids, glucose & electrolytes., tpn 1ltr triple chamber bag for central /peripheral vein contains protein 20-45 gm/l lipid 20-40gm/l glucose 80-160 gm/l, tpn solution 1000ml with amino acid, glucuse & carbohydartes electorlytes in triple chamber bag (center /peripheral)route, 3 in one tpn 1500ml for central/periperal iv emlusions with 80percentage olive 20percentage soya lipid, amino acids, glucose & electrolytes., tpn 1500ml triple chamber bag for central /peripheral vein contains protein 30-60 gm/l lipid 20-40gm/l glucose 80-160 gm/l, tpn solution 1500ml with amino acid, glucuse & carbohydartes electorlytes in triple chamber bag (center /peripheral)route, 3 in one tpn 2000ml for central/periperal iv emlusions with 80percentage olive 20percentage soya lipid, amino acids, glucose & electrolytes., tpn 2000ml triple chamber bag for central /peripheral vein contains protein 40-85 gm/l, lipid 40-80gm/l glucose 160-320 gm/l, tpn solution 2000ml with amino aciddddd, glucuse & carbohydartes electorlytes in triple chamber bag (center /peripheral)route, elastomeric infusor pump with 2ml/hr fixed delivery rate with normal filling volume of 96ml and maximum filling volume of 130ml. sterile and non pyrogeic fluid path, elastomeric infusor pump with 2/3/5 or 5/7/12 ml/hr variable delivery rate with normal filling volume of 96ml 240ml maximum filling volume of 300ml. sterile and non pyrogeic fluid path, elastomeric infusor pump with 5/7/12 ml/hr variable delivery rate with normal filling volume of 240ml maximum filling volume of 300ml. sterile and non pyrogeic fluid path, isotonic balanced crystrolis withour calcuim in self collapsable viaflo bag., tablet semaglutide 3mg, tablet semaglutide 7mg, tablet semaglutide 14mg, tablet empagliflogin 10mg + linagliptin 5mg, tablet empagliflogin 25mg + linagliptin 5mg, tablet sodium biocarbonate 1000mg, tablet sodium biocarbonate ec 650mg, tablet pottassium magnesium citrae + vit.b6, tablet hydated di-hydralazine sulfate 25mg, tablet tramadol hcl 18.75mg, acetaminiophen 162.5mg, tablet semaglutide 3mg, tablet semaglutide 7mg, tablet semaglutide 14mg, tablet empagliflogin 10mg + linagliptin 5mg, tablet empagliflogin 25mg + linagliptin 5mg, tablet sodium biocarbonate 1000mg, tablet sodium biocarbonate ec 650mg, tablet pottassium magnesium citrae + vit.b6, tablet hydated di-hydralazine sulfate 25mg, tablet tramadol hcl 18.75mg, acetaminiophen 162.5mg, tablet nicorandil 2mg, tab. resperidone 0.2mg, tab. lansoprazole orally disintegrating 15mg, tab. clomipramine 25mg, inj. tobramycin 80mg/2ml, inj. alprostadil 500mcg/ml, inj. methocarbamol 100mg/ml 10ml, inj. minocycline 100mg, inj. tocilizumab 80mg, inj. tocilizumab 200mg, inj. tocilizumab 400mg, inj. remdesivir 100mg, inj. lacosamide 10mg/ml, inj. sovateltide 30mcg, spacer for inhaler, inhaler vilanterol, glycopyrronium and fluticasone furoate 12.5mcg, 25mcg, 100mcg, inhaler vilanterol 25mcg + glycopyrronium 50mcg + fluticasone furoate 100mcg, rotacap umeclidinium 62.5mcg + vilanterol 25mcg + fluticasone furoate 100mcg, rotacap glycopyronium 25mcg + formeterol furoate 12mcg, rotacap glycopyronium 50mcg, respules ipravent 2ml, respules budesonide 0.5mg, charcoal powder 50gm, charcoal powder 100gm, charcoal powder 500gm, steril ophthalmic irrigating solution 250mg, steril ophthalmic irrigating solution 500mg, tulobuterol transdermal patch 1mg, tulobuterol transdermal patch 2mg, rivastigmine transdermal patch 9mg, tablet almotriptan 6.25mg, tablet almotriptan 12.5mg, tablet teriflunomide 7mg, tablet teriflunomide 14mg, tablet dimethyl fumarate 120mg (delayed relese tab.), tablet dimethyl fumarate 240mg (delayed relese tab.), tablet cenobamate 12.5mg, tablet cenobamate 25mg, tablet cenobamate 50mg, tablet cenobamate 75mg, tablet pitolisant 4.45mg, tablet pitolisant 17.8mg

Corrigendum

Sr No Corrigendum Date Corrigendum Type New Submission Date
1 N/A 27-Oct-2026

BOQ

Sl. No. Item Name
1cyclosporine emulsion 0.05percentage + glycerine, castor oil, polysorbate 80, carbomar 1342 (per unim 0.4ml each)
2Dorzolamide (2percentage) & Timolol (0.5percentage) Eye Drops
3Flubiprofen 0.3percentage drops.
4Flurbiprofen Sodium 0.03percentage W/V + Hydroxy prophyl Methyl Cellulose ( HPMC) -0.25percentage + Polymercuric Nitrate -0.002percentage W/v
5Gentamycin Sulphate 0.3percentage with Dexamethasone drops
6Nepafenac micronized suspension 0.1percentage with Stabilzed Oxychloro Complex ( Purite) (BAK Free)
7Nephazolin Hcl 0.1percentage Methyl cellulose 0.1percentage Chloepheniramine Meleate 0.01percentage Phenyl mercuric nitrate 0.001percentage Eye drops.
8Ofloxacin 0.3percentage with Dexamethasone 0.1percentage eye/ear drops.
9Ofloxacin Eye/Ear Drops. 0.3percentage
10Sterile Opthalmic irrigating Solution
11Sterile Opthalmic irrigating Solution Balanced salt solution contains: NaCl 0.49percentage, KCl-0.075percentage CaCl-0.3percentage, Sod.Acetate 0.39percentage Sod.citrate 0.17percentage Q.S.H2O.for Inj. (Glass Bottle) Autoclavable
12Tobramycin 0.3percentage eye drosp.
13Paediatric Department items: Ambroxol Hydrochloride Syrup
14Amoxycillin and clavulinic acid Syrup
15B-Complex Syrup.
16Caffine Citrate (1ml-20mg) 1.5ml Vial Syrup
17Caffine Citrate (1ml-20mg) 1ml Vial Syrup
18Caffine Citrate (1ml-20mg) 3ml Vial Syrup
19Calcium,Phosphorus,Magnasium,Zinc & Vitamin D3 Syrup
20Cefpodoxime Syrup
21Codeine Syrup
22Cough Syrup Containing:Yashtimadhu (Glycyrrhiza glabra), Tulasi ( Ocimum sactum), Madhu ( Mel despumatum), Kantakari (Solanum xanthocarpum), VasakaAdhatoda vasica) vidanga( Embelia ribes), Draksha ( Vitis Vinifera), Jatipatri (Myristica Fragrans), Guggulu (Balsamodendron mukul)
23Dextrometharphan Hydrobromide + CPM + Phenylephrine Syp.
24Digoxin Syrup
25Each 100 gram of cream contains: Aqueous extract of Triticum Vulgare 15 gm + phenoxyethanol 1gm
26Erythromycin ( 125mg / 5ml ) Syrup
27FERACRYLUM 1percentage v/v Solution- 100ml Bottle
28Frusemide Syrup
29Iron drops
30Levocarnitine (1ml equal to 100mg) Syrup
31Levosalbutamol Syrup
32Linezolid Syrup
33Lugol's Iodine Solution (3.5percentage)
34Metoclopramide Hydrochloride (5mg/5ml) Syrup
35Phenytion Syrup
36Pottassium Chloride Syrup
37Promethazine Syrup 5mg/5ml.
38Rifaximin suspension100 mg/5ml
39Vitamin D3 (800iu/ml)
40Vitamin -E (400IU/ml) Syrup
41Zidovudine Syrup
42Respiratory Medicine department items: Levosalbutamol Respules + Ipratropium Bromid Respules
43Nebulization Respules ( Glycopyronium)
44Nebulization Respules (Ipratropium + Levosalbutamol)
45Formeterol 20 microgram+Budesonide 0.5 gm respules
46Formeterol 20 microgram+Budesonide 1 gm respules
47Buprinorphin 10mcg Patch
48Buprinorphin 20mcg Patch
49Buprinorphin 5mcg Patch
50Dextrose Powder IP
51Protein Powder 200 gms with Vit A,B1,B2,B6
52Paediatric department items: Human Milk Fortifier (1gm Sachet)
53Mther milk Fortifier (0.5gm Sachet)
54Mther milk Fortifier (1gm Sachet)
55Probiotic sachet for Neonatal Use
56SIMYL MCT Oil 100ml
57Radiology Department items: Ultrasound Contrast Sulpher Hexafluride
58Iodixanol 320mg Non Ionic, Dimeric ISO Osmolar U.S. FDA Approved CT Contrast Injection
59Iodixanol 320mg/ml Injection
60Iohexol 300mg Non Ionic, Low Osmolar with Low Viscosity U.S. FDA Approved CT Contrast Injection
61Iopamidol Solution 300mg/ml Injection
62Iopamidol Solution 350mg/ml Injection
63Oral Contrast for C.T. Scan 10gm.Sodium Diatrizoate 66gm. Meglumine Diatrizoate
64Oral Contrast for C.T. Scan Barium Sulphate Solution For C.T. Scan I.P. 7gm/100ml.
65Oral Negative Contrast Mannitol
66SodaLime - Highco2 absorption capacity, It should be in pallete form having high and uniform packing density.It should be high abrasion resistant due to less dust formation. There should be no compound A and carbon monoxide formation
67Terpentine Oil.
68Succinylated Balance Gelatin for 4percentage Succinylated Gelatin molecule with a molecular weight of 30,000 daltons Sodium- 151mmol/l Potassium- 4 mmol/l, Calcium- 1 mmol/l Magnesium- 1 mmol/l, Acetate- 24.0, Chloride- 103mmol/l, pH- 7.4, Osmolality- 284 mOsm/kg In a 500ml specially patented plastic “Ecoflac Plus” bottle
69Succinylated Gelatin for 4percentage Succinylated Gelatin molecule with a molecular weight of 30,000 daltons containing Na+ : 154 mmol/L and Cl- : 120 mmol/L, with a colloid osmotic pressure of 33.3 mm of Hg; In a 500ml specially patented plastic “Ecoflac Plus” bottle
70Tablet Lactoferrin 100mg +Disodium Guanosine 5 -Monophosphate 10mg
71Tablet Lactoferrin 100mg +Disodium Guanosine 5 -Monophosphate 10mg + Magnesium 200mg
72Carboxy methyl cellulose (1.0percentage)+ Stabilized Oxychloro Complex ( Purite) - 0.0075percentage with Boric acid, Cacl, Mgcl , Sodium Borate, Nacl
73Carboxy methyl cellulose (0.5percentage)+ Stabilized Oxychloro Complex ( Purite) - 0.005percentage
74Injection Dexamethasone 0.7mg Intravitreal Implant
75Injection Botulinum toxin type A 200 Unit
76Fast Acting Insulin Aspart 100iu/ml in 3ml PFS Type of Insulin:Ultra Short Acting Prandial
77Injection Concizumab 15mg Pen Device
78Injection Concizumab 300mg Pen Device
79Human Papillomavirus 9-valent Vaccine 0.5ml
80Human Albumin Solution I.P. 5percentage 250ml
81Human Albumin Solution I.P. 25percentage 100ml
82Injection Agalsidase Alfa (r-DNA origin)1mg/ml
83Injection Idursulfase (r-DNA origin)2mg/ml
84Injection Velaglucerase Alfa (r-DNA origin) 4.0ml
85Injection Vedolizumab 300mg
86Human C1 Esterase Inhibitor 500iu E.P.
87Injection Semagluide 0.25mg
88Injection Semagluide 0.5mg
89Injection Semagluide 1.0mg
90Injection Semagluide 1.7mg
91Injection Semagluide 2.4mg
92Injection Pegylated FactorVIII (250IU/Vial)
93Injection Pegylated FactorVIII (500IU/Vial)
94Nonacog Beta Pegol, Glycopegylated Recombinant Factor-IX 250IU
95Nonacog Beta Pegol, Glycopegylated Recombinant Factor-IX 1000IU
96Hemostsit Gelatin Thrombin Matrix 2500IU
97Thrombin + Fibrin Seant 2ml
98Lactoferrin 100mg+ Ferroue bisglycinate 200mg+ Folic Acid 400mcg
993 in one TPN 1000ml for Central/Periperal IV Emlusions with 80percentage Olive 20percentage Soya Lipid, Amino acids, glucose & Electrolytes.
100TPN 1Ltr Triple chamber bag for central /Peripheral vein contains Protein 20-45 gm/L Lipid 20-40gm/L Glucose 80-160 gm/L
101TPN Solution 1000ml with Amino Acid, glucuse & Carbohydartes Electorlytes in Triple chamber bag (Center /Peripheral)Route
1023 in one TPN 1500ml for Central/Periperal IV Emlusions with 80percentage Olive 20percentage Soya Lipid, Amino acids, glucose & Electrolytes.
103TPN 1500ml Triple chamber bag for central /Peripheral vein contains Protein 30-60 gm/L Lipid 20-40gm/L Glucose 80-160 gm/L
104TPN Solution 1500ml with Amino Acid, glucuse & Carbohydartes Electorlytes in Triple chamber bag (Center /Peripheral)Route
1053 in one TPN 2000ml for Central/Periperal IV Emlusions with 80percentage Olive 20percentage Soya Lipid, Amino acids, glucose & Electrolytes.
106TPN 2000ml Triple chamber bag for central /Peripheral vein contains Protein 40-85 gm/L, Lipid 40-80gm/L Glucose 160-320 gm/L
107TPN Solution 2000ml with Amino Aciddddd, glucuse & Carbohydartes Electorlytes in Triple chamber bag (Center /Peripheral)Route
108Elastomeric infusor Pump with 2ml/hr fixed Delivery rate with normal filling volume of 96ml and Maximum filling volume of 130ml. Sterile and Non Pyrogeic fluid path
109Elastomeric infusor Pump with 2/3/5 or 5/7/12 ml/hr variable Delivery rate with normal filling volume of 96ml 240ml Maximum filling volume of 300ml. Sterile and Non Pyrogeic fluid path
110Elastomeric infusor Pump with 5/7/12 ml/hr variable Delivery rate with normal filling volume of 240ml Maximum filling volume of 300ml. Sterile and Non Pyrogeic fluid path
111Isotonic Balanced crystrolis withour Calcuim in self collapsable viaflo Bag.
112Tablet Semaglutide 3mg
113Tablet Semaglutide 7mg
114Tablet Semaglutide 14mg
115Tablet Empagliflogin 10mg + Linagliptin 5mg
116Tablet Empagliflogin 25mg + Linagliptin 5mg
117Tablet Sodium Biocarbonate 1000mg
118Tablet Sodium Biocarbonate EC 650mg
119Tablet Pottassium Magnesium citrae + Vit.B6
120Tablet Hydated Di-Hydralazine Sulfate 25mg
121Tablet Tramadol HCL 18.75MG, Acetaminiophen 162.5mg
122Tablet Semaglutide 3mg
123Tablet Semaglutide 7mg
124Tablet Semaglutide 14mg
125Tablet Empagliflogin 10mg + Linagliptin 5mg
126Tablet Empagliflogin 25mg + Linagliptin 5mg
127Tablet Sodium Biocarbonate 1000mg
128Tablet Sodium Biocarbonate EC 650mg
129Tablet Pottassium Magnesium citrae + Vit.B6
130Tablet Hydated Di-Hydralazine Sulfate 25mg
131Tablet Tramadol HCL 18.75MG, Acetaminiophen 162.5mg
132Tablet Nicorandil 2mg
133Tab. Resperidone 0.2mg
134Tab. Lansoprazole orally Disintegrating 15mg
135Tab. Clomipramine 25mg
136Inj. Tobramycin 80mg/2ml
137Inj. Alprostadil 500mcg/ml
138Inj. Methocarbamol 100mg/ml 10ml
139Inj. Minocycline 100mg
140Inj. Tocilizumab 80mg
141Inj. Tocilizumab 200mg
142Inj. Tocilizumab 400mg
143Inj. Remdesivir 100mg
144Inj. Lacosamide 10mg/ml
145Inj. Sovateltide 30mcg
146Spacer for Inhaler
147Inhaler Vilanterol, Glycopyrronium and Fluticasone furoate 12.5mcg, 25mcg, 100mcg
148Inhaler Vilanterol 25mcg + Glycopyrronium 50mcg + Fluticasone furoate 100mcg
149Rotacap Umeclidinium 62.5mcg + Vilanterol 25mcg + Fluticasone Furoate 100mcg
150Rotacap Glycopyronium 25mcg + Formeterol Furoate 12mcg
151Rotacap Glycopyronium 50mcg
152Respules Ipravent 2ml
153Respules Budesonide 0.5mg
154Charcoal Powder 50gm
155Charcoal Powder 100gm
156Charcoal Powder 500gm
157Steril ophthalmic Irrigating Solution 250mg
158Steril ophthalmic Irrigating Solution 500mg
159Tulobuterol Transdermal Patch 1mg
160Tulobuterol Transdermal Patch 2mg
161Rivastigmine Transdermal Patch 9mg
162Tablet Almotriptan 6.25mg
163Tablet Almotriptan 12.5mg
164Tablet Teriflunomide 7mg
165Tablet Teriflunomide 14mg
166Tablet Dimethyl Fumarate 120mg (Delayed Relese tab.)
167Tablet Dimethyl Fumarate 240mg (Delayed Relese tab.)
168Tablet Cenobamate 12.5mg
169Tablet Cenobamate 25mg
170Tablet Cenobamate 50mg
171Tablet Cenobamate 75mg
172Tablet Pitolisant 4.45mg
173Tablet Pitolisant 17.8mg

AI Tender Summary

OUR REF NO 57744626
AUTHORITY Government Departments
TENDER VALUE Ref. Documents
LAST DATE 27-10-2026
Authority
Authority Name Health And Family Welfare Department
Work Description Tender for Tablet ,Injection and Miscellaneous Items D (Non EDL items) 2026-27- cyclosporine emulsion 0.05percentage + glycerine, castor oil, polysorbate 80, carbomar 1342 (per unim 0.4ml each), dorzolamide (2percentage) & timolol (0.5percentage) eye drops, flubiprofen 0.3percentage drops., flurbiprofen sodium 0.03percentage w/v + hydroxy prophyl methyl cellulose ( hpmc) -0.25percentage + polymercuric nitrate -0.002percentage w/v, gentamycin sulphate 0.3percentage with dexamethasone drops, nepafenac micronized suspension 0.1percentage with stabilzed oxychloro complex ( purite) (bak free), nephazolin hcl 0.1percentage methyl cellulose 0.1percentage chloepheniramine meleate 0.01percentage phenyl mercuric nitrate 0.001percentage eye drops., ofloxacin 0.3percentage with dexamethasone 0.1percentage eye/ear drops., ofloxacin eye/ear drops. 0.3percentage, sterile opthalmic irrigating solution, sterile opthalmic irrigating solution balanced salt solution contains: nacl 0.49percentage, kcl-0.075percentage cacl-0.3percentage, sod.acetate 0.39percentage sod.citrate 0.17percentage q.s.h2o.for inj. (glass bottle) autoclavable, tobramycin 0.3percentage eye drosp., paediatric department items: ambroxol hydrochloride syrup, amoxycillin and clavulinic acid syrup, b-complex syrup., caffine citrate (1ml-20mg) 1.5ml vial syrup, caffine citrate (1ml-20mg) 1ml vial syrup, caffine citrate (1ml-20mg) 3ml vial syrup, calcium,phosphorus,magnasium,zinc & vitamin d3 syrup, cefpodoxime syrup, codeine syrup, cough syrup containing:yashtimadhu (glycyrrhiza glabra), tulasi ( ocimum sactum), madhu ( mel despumatum), kantakari (solanum xanthocarpum), vasakaadhatoda vasica) vidanga( embelia ribes), draksha ( vitis vinifera), jatipatri (myristica fragrans), guggulu (balsamodendron mukul), dextrometharphan hydrobromide + cpm + phenylephrine syp., digoxin syrup, each 100 gram of cream contains: aqueous extract of triticum vulgare 15 gm + phenoxyethanol 1gm, erythromycin ( 125mg / 5ml ) syrup, feracrylum 1percentage v/v solution- 100ml bottle, frusemide syrup, iron drops, levocarnitine (1ml equal to 100mg) syrup, levosalbutamol syrup, linezolid syrup, lugols iodine solution (3.5percentage), metoclopramide hydrochloride (5mg/5ml) syrup, phenytion syrup, pottassium chloride syrup, promethazine syrup 5mg/5ml., rifaximin suspension100 mg/5ml, vitamin d3 (800iu/ml), vitamin -e (400iu/ml) syrup, zidovudine syrup, respiratory medicine department items: levosalbutamol respules + ipratropium bromid respules, nebulization respules ( glycopyronium), nebulization respules (ipratropium + levosalbutamol), formeterol 20 microgram+budesonide 0.5 gm respules, formeterol 20 microgram+budesonide 1 gm respules, buprinorphin 10mcg patch, buprinorphin 20mcg patch, buprinorphin 5mcg patch, dextrose powder ip, protein powder 200 gms with vit a,b1,b2,b6, paediatric department items: human milk fortifier (1gm sachet), mther milk fortifier (0.5gm sachet), mther milk fortifier (1gm sachet), probiotic sachet for neonatal use, simyl mct oil 100ml, radiology department items: ultrasound contrast sulpher hexafluride, iodixanol 320mg non ionic, dimeric iso osmolar u.s. fda approved ct contrast injection, iodixanol 320mg/ml injection, iohexol 300mg non ionic, low osmolar with low viscosity u.s. fda approved ct contrast injection, iopamidol solution 300mg/ml injection, iopamidol solution 350mg/ml injection, oral contrast for c.t. scan 10gm.sodium diatrizoate 66gm. meglumine diatrizoate, oral contrast for c.t. scan barium sulphate solution for c.t. scan i.p. 7gm/100ml., oral negative contrast mannitol, sodalime - highco2 absorption capacity, it should be in pallete form having high and uniform packing density.it should be high abrasion resistant due to less dust formation. there should be no compound a and carbon monoxide formation, terpentine oil., succinylated balance gelatin for 4percentage succinylated gelatin molecule with a molecular weight of 30,000 daltons sodium- 151mmol/l potassium- 4 mmol/l, calcium- 1 mmol/l magnesium- 1 mmol/l, acetate- 24.0, chloride- 103mmol/l, ph- 7.4, osmolality- 284 mosm/kg in a 500ml specially patented plastic ecoflac plus bottle, succinylated gelatin for 4percentage succinylated gelatin molecule with a molecular weight of 30,000 daltons containing na+ : 154 mmol/l and cl- : 120 mmol/l, with a colloid osmotic pressure of 33.3 mm of hg; in a 500ml specially patented plastic ecoflac plus bottle, tablet lactoferrin 100mg +disodium guanosine 5 -monophosphate 10mg, tablet lactoferrin 100mg +disodium guanosine 5 -monophosphate 10mg + magnesium 200mg, carboxy methyl cellulose (1.0percentage)+ stabilized oxychloro complex ( purite) - 0.0075percentage with boric acid, cacl, mgcl , sodium borate, nacl, carboxy methyl cellulose (0.5percentage)+ stabilized oxychloro complex ( purite) - 0.005percentage, injection dexamethasone 0.7mg intravitreal implant, injection botulinum toxin type a 200 unit, fast acting insulin aspart 100iu/ml in 3ml pfs type of insulin:ultra short acting prandial, injection concizumab 15mg pen device, injection concizumab 300mg pen device, human papillomavirus 9-valent vaccine 0.5ml, human albumin solution i.p. 5percentage 250ml, human albumin solution i.p. 25percentage 100ml, injection agalsidase alfa (r-dna origin)1mg/ml, injection idursulfase (r-dna origin)2mg/ml, injection velaglucerase alfa (r-dna origin) 4.0ml, injection vedolizumab 300mg, human c1 esterase inhibitor 500iu e.p., injection semagluide 0.25mg, injection semagluide 0.5mg, injection semagluide 1.0mg, injection semagluide 1.7mg, injection semagluide 2.4mg, injection pegylated factorviii (250iu/vial), injection pegylated factorviii (500iu/vial), nonacog beta pegol, glycopegylated recombinant factor-ix 250iu, nonacog beta pegol, glycopegylated recombinant factor-ix 1000iu, hemostsit gelatin thrombin matrix 2500iu, thrombin + fibrin seant 2ml, lactoferrin 100mg+ ferroue bisglycinate 200mg+ folic acid 400mcg, 3 in one tpn 1000ml for central/periperal iv emlusions with 80percentage olive 20percentage soya lipid, amino acids, glucose & electrolytes., tpn 1ltr triple chamber bag for central /peripheral vein contains protein 20-45 gm/l lipid 20-40gm/l glucose 80-160 gm/l, tpn solution 1000ml with amino acid, glucuse & carbohydartes electorlytes in triple chamber bag (center /peripheral)route, 3 in one tpn 1500ml for central/periperal iv emlusions with 80percentage olive 20percentage soya lipid, amino acids, glucose & electrolytes., tpn 1500ml triple chamber bag for central /peripheral vein contains protein 30-60 gm/l lipid 20-40gm/l glucose 80-160 gm/l, tpn solution 1500ml with amino acid, glucuse & carbohydartes electorlytes in triple chamber bag (center /peripheral)route, 3 in one tpn 2000ml for central/periperal iv emlusions with 80percentage olive 20percentage soya lipid, amino acids, glucose & electrolytes., tpn 2000ml triple chamber bag for central /peripheral vein contains protein 40-85 gm/l, lipid 40-80gm/l glucose 160-320 gm/l, tpn solution 2000ml with amino aciddddd, glucuse & carbohydartes electorlytes in triple chamber bag (center /peripheral)route, elastomeric infusor pump with 2ml/hr fixed delivery rate with normal filling volume of 96ml and maximum filling volume of 130ml. sterile and non pyrogeic fluid path, elastomeric infusor pump with 2/3/5 or 5/7/12 ml/hr variable delivery rate with normal filling volume of 96ml 240ml maximum filling volume of 300ml. sterile and non pyrogeic fluid path, elastomeric infusor pump with 5/7/12 ml/hr variable delivery rate with normal filling volume of 240ml maximum filling volume of 300ml. sterile and non pyrogeic fluid path, isotonic balanced crystrolis withour calcuim in self collapsable viaflo bag., tablet semaglutide 3mg, tablet semaglutide 7mg, tablet semaglutide 14mg, tablet empagliflogin 10mg + linagliptin 5mg, tablet empagliflogin 25mg + linagliptin 5mg, tablet sodium biocarbonate 1000mg, tablet sodium biocarbonate ec 650mg, tablet pottassium magnesium citrae + vit.b6, tablet hydated di-hydralazine sulfate 25mg, tablet tramadol hcl 18.75mg, acetaminiophen 162.5mg, tablet semaglutide 3mg, tablet semaglutide 7mg, tablet semaglutide 14mg, tablet empagliflogin 10mg + linagliptin 5mg, tablet empagliflogin 25mg + linagliptin 5mg, tablet sodium biocarbonate 1000mg, tablet sodium biocarbonate ec 650mg, tablet pottassium magnesium citrae + vit.b6, tablet hydated di-hydralazine sulfate 25mg, tablet tramadol hcl 18.75mg, acetaminiophen 162.5mg, tablet nicorandil 2mg, tab. resperidone 0.2mg, tab. lansoprazole orally disintegrating 15mg, tab. clomipramine 25mg, inj. tobramycin 80mg/2ml, inj. alprostadil 500mcg/ml, inj. methocarbamol 100mg/ml 10ml, inj. minocycline 100mg, inj. tocilizumab 80mg, inj. tocilizumab 200mg, inj. tocilizumab 400mg, inj. remdesivir 100mg, inj. lacosamide 10mg/ml, inj. sovateltide 30mcg, spacer for inhaler, inhaler vilanterol, glycopyrronium and fluticasone furoate 12.5mcg, 25mcg, 100mcg, inhaler vilanterol 25mcg + glycopyrronium 50mcg + fluticasone furoate 100mcg, rotacap umeclidinium 62.5mcg + vilanterol 25mcg + fluticasone furoate 100mcg, rotacap glycopyronium 25mcg + formeterol furoate 12mcg, rotacap glycopyronium 50mcg, respules ipravent 2ml, respules budesonide 0.5mg, charcoal powder 50gm, charcoal powder 100gm, charcoal powder 500gm, steril ophthalmic irrigating solution 250mg, steril ophthalmic irrigating solution 500mg, tulobuterol transdermal patch 1mg, tulobuterol transdermal patch 2mg, rivastigmine transdermal patch 9mg, tablet almotriptan 6.25mg, tablet almotriptan 12.5mg, tablet teriflunomide 7mg, tablet teriflunomide 14mg, tablet dimethyl fumarate 120mg (delayed relese tab.), tablet dimethyl fumarate 240mg (delayed relese tab.), tablet cenobamate 12.5mg, tablet cenobamate 25mg, tablet cenobamate 50mg, tablet cenobamate 75mg, tablet pitolisant 4.45mg, tablet pitolisant 17.8mg
Basic Detail
Tender No 2026-27
Bidding Type Tender
Location
City Surat
State Gujarat
Key Dates
Publish Date 01 Jan 0001
Submission Date 27 Oct 2026
Open Date 01 Jan 0001
Finance
Tender Value Ref. Documents
Tender Fee 5000
EMD Ref. Documents
Exemption Not Available
Document List
fa024f9e1b0b48478bacf57868edbc13.html
FinaltenderdocumentTabletandinj.pdf

Unlock Full AI Tender Summary

Get instant access to the complete AI-generated analysis — scope, eligibility, timeline & more.

Instant Access Secure Free
Your details are secure and used only for document delivery.

Tender Timeline

Sep 30, 2026
11:30 IST

Tender Published

Tender notice published.

Today
Oct 27, 2026
18:00 IST

Corrigendum-1 Issued

Clarifications on tender conditions and amendments issued.

Upcoming · 27 days
Oct 27, 2026
17:00 IST

Bid Submission Deadline

Online submission via eProcurement portal.

Upcoming · 27 days

Tender Documents

Download All (ZIP) ↓
html

fa024f9e1b0b48478bacf57868edbc13.html

pdf

FinaltenderdocumentTabletandinj.pdf

Disclaimer

We takes all possible care for accurate & authentic tender information. However users are requested to refer Original source of Tender Notice / Tender Document published by Tender Issuing Agency before taking any call regarding this tender

TenderDetail
Loading tenders